Search results for "DISORDERS"

showing 10 items of 4560 documents

Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa.

2018

INTRODUCTION: Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease which has been associated with an increased risk of adverse cardiovascular (CV) outcomes. Adequate stratification of the CV risk is an issue of major importance in patients with HS. To analyze the usefulness of carotid ultrasound (US) assessment for the CV disease risk stratification compared with a traditional score, the Framingham risk score (FRS), in a series of patients with HS. METHODS: Cross-sectional study of 60 patients with HS without history of CV events, diabetes mellitus or chronic kidney disease. Information on CV risk factors was collected and the FRS was calculated. Thus, the patients were…

medicine.medical_specialtyanimal structuresCross-sectional studyEndocrine DisordersInflammatory DiseasesCardiologylcsh:MedicineBlood PressureDiseaseVascular MedicineBiochemistry030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicineMedicine and Health SciencesDiabetes MellitusMedicineHumansCoronary Heart DiseaseIn patientHidradenitis suppurativalcsh:Science030203 arthritis & rheumatologyMultidisciplinaryFramingham Risk Scorebusiness.industrylcsh:RBiology and Life SciencesHealth Risk Analysismedicine.diseaseAtherosclerosisLipidsHidradenitis SuppurativaHealth CareBlood pressureCarotid ArteriesCross-Sectional StudiesCholesterolROC CurveCardiovascular DiseasesMetabolic Disorderslcsh:QbusinessKidney diseaseResearch ArticlePLoS ONE
researchProduct

The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Pl…

2021

Background: The ISTH Bleeding Assessment Tool (ISTH-BAT) has been validated for clinical screening of suspected von Willebrand disease (VWD) and for bleeding prediction. Recently it has been validated for subjects with inherited platelet disorders (IPD) (BAT-VAL study). Objectives: To determine whether the ISTH-BAT bleeding score (BS) predicts subsequent bleeding events requiring treatment in IPD patients. Methods: Patients with IPD, type 1 VWD (VWD-1) and age- and sex-matched healthy controls enrolled in the BAT-VAL study were prospectively followed-up for 2 years and bleeding episodes requiring treatment were recorded. Results: Of the 1098 subjects initially enrolled, 955 were followed-up…

medicine.medical_specialtyanimal structuresmild&#8208Platelet Function TestsPlatelet disorderinherited platelet disorderHemorrhage030204 cardiovascular system & hematologyHemorrhage/diagnosis03 medical and health sciences0302 clinical medicineVon Willebrand factorhemic and lymphatic diseasesInternal medicinevon Willebrand FactorVon Willebrand diseaseMedicineHumansPlateletBleeding prediction Bleeding score Blood platelet disorders Child Communication Hemorrhage Humans Inherited platelet disorders Mild-moderate bleeding disorders Platelet Function Tests von Willebrand diseases von Willebrand FactorChildBlood Platelet Disordersddc:616mild-moderate bleeding disordersbiologybusiness.industrymild-moderate bleeding disorderIncidence (epidemiology)CommunicationSettore MED/09 - MEDICINA INTERNAbleeding predictionvon Willebrand Diseases/diagnosis/genetics[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHematologymedicine.diseaseBlood Platelet Disorders/diagnosis/genetics3. Good healthbleeding scoreInstitutional repositoryvon Willebrand Diseasesmoderate bleeding disordersinherited platelet disordersQuartilebiology.proteinBlood Platelet Disordersvon Willebrand diseasebusinessJournal of thrombosis and haemostasis : JTHREFERENCES
researchProduct

A Preliminary Study on Cranio-Facial Characteristics Associated with Minor Neurological Dysfunctions (MNDs) in Children with Autism Spectrum Disorder…

2020

Background. Craniofacial anomalies and minor neurological dysfunction (MNDs) have been identified, in literature, as risk factors for neurodevelopmental disorders. They represent physical indicators of embryonic development suggesting a possible contributory role of complications during early, even pre-conceptional, phases of ontogeny in autism spectrum disorders (ASD). Limited research has been conducted about the co-occurrence of the two biomarkers in children with ASD. This study investigates the associative patterns of cranio-facial anomalies and MNDs in ASD children, and whether these neurodevelopmental markers correlate with intensity of ASD symptoms and overall functioning. Methods. …

medicine.medical_specialtyautism spectrum disordersNeurological examinationAudiologyArticlelcsh:RC321-57103 medical and health sciencesMuscle tone0302 clinical medicinemental disordersmorphologyMedicine0501 psychology and cognitive sciencesAutism spectrum disorders Minor neurological dysfunctions Morphology NeurodevelopmentCraniofaciallcsh:Neurosciences. Biological psychiatry. NeuropsychiatryCephalic indexmedicine.diagnostic_testneurodevelopmentbusiness.industryGeneral Neuroscience05 social sciencesCognitionAnthropometrymedicine.diseasemedicine.anatomical_structureChildhood Autism Rating ScaleAutismminor neurological dysfunctionsbusiness030217 neurology & neurosurgery050104 developmental & child psychologyBrain Sciences
researchProduct

Autism and Migraine: An Unexplored Association?

2020

Autism spectrum disorder is characterized by neurological, psychiatric and medical comorbidities—some conditions co-occur so frequently that comorbidity in autism is the rule rather than the exception. The most common autism co-occurring conditions are intellectual disability, language disorders, attention-deficit hyperactivity disorder, epilepsy, gastrointestinal problems, sleep disorders, anxiety, depression, obsessive-compulsive disorder, psychotic disorders, oppositional defiant disorder, and eating disorders. They are well known and studied. Migraine is the most common brain disease in the world, but surprisingly only a few studies investigate the comorbidity between autism and migrain…

medicine.medical_specialtyautismReviewbehavioral disciplines and activitiesASDlcsh:RC321-57103 medical and health sciencesEpilepsy0302 clinical medicineIntellectual disabilitymental disordersmedicinemigrainepainPsychiatrylcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biology0303 health sciencesbusiness.industryGeneral Neurosciencemedicine.diseaseComorbidityEating disordersMigraineAutism spectrum disorderAutismAnxietymedicine.symptombusinessheadache030217 neurology & neurosurgeryBrain Sciences
researchProduct

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwi…

2016

Background: Interleukin (IL)-1 inhibitors have been suggested as possible therapeutic options in a large number of old and new clinical entities characterized by an IL-1 driven pathogenesis. Objectives: To perform a nationwide snapshot of the on-label and off-label use of anakinra (ANA) and canakinumab (CAN) for different conditions both in children and adults. Methods: We retrospectively collected demographic, clinical, and therapeutic data from both adult and pediatric patients treated with IL-1 inhibitors from January 2008 to July 2016. Results: Five hundred and twenty-six treatment courses given to 475 patients (195 males, 280 females; 111 children and 364 adults) were evaluated. ANA wa…

medicine.medical_specialtyautoinflammatory disorders treatment interleukin (IL)-1 anakinra canakinumabDoseanakinra; autoinflammatory disorders; canakinumab; interleukin (IL)-1; treatmentautoinflammatory disorders; treatment; interleukin (IL)-1; anakinra; canakinumab030204 cardiovascular system & hematologyOff-label usecanakinumab03 medical and health sciencesSettore MED/38 - Pediatria Generale E Specialistica0302 clinical medicineInternal medicinemedicinePharmacology (medical)Interleukin-1 inhibitorsAdverse effectOriginal Research030203 arthritis & rheumatologyPharmacologyAnakinratreatmentbusiness.industrylcsh:RM1-950Anakinra; Autoinflammatory disorders; Canakinumab; Interleukin (IL)-1; Treatment; Pharmacology; Pharmacology (medical)InterleukinRetrospective cohort studySurgeryinterleukin (IL)-1Canakinumablcsh:Therapeutics. PharmacologyAutoinflammatory disorderSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAautoinflammatory disordersAntirheumatic drugsbusinessmedicine.druganakinra
researchProduct

An mHealth App for Supporting Quitters to Manage Cigarette Cravings With Short Bouts of Physical Activity: A Randomized Pilot Feasibility and Accepta…

2016

BackgroundWhile gains in reducing smoking rates in Finland have been made, prevalence rates are still substantial. Relapse rates among smokers engaged in quit-smoking programs are high. Physical activity has been proposed as one means to help smokers manage cravings. Software and apps on mobile phone and handheld devices offer an opportunity to communicate messages on how to use physical activity to manage cravings as part of quit-smoking programs. ObjectiveWe aimed to test the feasibility, acceptability, usability, and preliminary efficacy of an mHealth mobile phone app, Physical activity over Smoking (PhoS), to assist smokers in quitting smoking in a randomized controlled trial. The app w…

medicine.medical_specialtybehavior change020205 medical informaticsmedia_common.quotation_subjectphysical activityHealth Informatics02 engineering and technologyInformation technologyliikuntaRelapse preventionsmokinglaw.invention03 medical and health sciencesphysical training0302 clinical medicineRandomized controlled triallawtupakointikäyttäytymismallitIntervention (counseling)mental disorders0202 electrical engineering electronic engineering information engineeringmedicinemobiilisovellukset030212 general & internal medicineta315mHealthrelapse preventionmedia_commonmobile appsOriginal Paperbusiness.industrywithdrawalPublic healthBehavior changebehavioural patternsUsabilityta3141ta3142vieroitusAbstinenceT58.5-58.64mHealth appmHealthrandomized controlled trialPhysical therapyPublic aspects of medicineRA1-1270businessJMIR Mhealth Uhealth
researchProduct

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration fi…

2016

BACKGROUND Salivary α-amylase (sAA) activity alternations are observed in major depressive disorder (MDD) being associated with depression severity and its specific psychopathological dimensions with anxiety being attributed to distress. No data is available on sAA in MDD according to Hamilton Rating Scale for Depression (HAMD-17) and State-Trait Anxiety Inventory (STAI). The exploratory study examines whether and to what extent baseline sAA level is interrelated to the psychopathological features including severity of symptoms and specific psychopathological dimensions. MATERIAL AND METHODS The basal, non-stimulated sAA activity was studied in 20 non-late-life adult, treatment-naive MDD pa…

medicine.medical_specialtybehavioral disciplines and activities03 medical and health sciences0302 clinical medicinemental disordersmedicinePsychiatryGeneral DentistryFirst episodebusiness.industryResearchHamilton Rating Scale for Depressionmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Community and Preventive Dentistry030227 psychiatryDrug-naïveDistressstomatognathic diseasesUNESCO::CIENCIAS MÉDICASMajor depressive disorderAnxietymedicine.symptombusiness030217 neurology & neurosurgeryState-Trait Anxiety Inventorymedicine.drugPsychopathologyJournal of clinical and experimental dentistry
researchProduct

Aspects of disordered eating continuum in elite high-intensity sports

2010

Dieting is an important risk factor for disordered eating and eating disorders. Disordered eating occurs on a continuum from dieting and restrictive eating, abnormal eating behavior, and finally clinical eating disorders. The prevalence of eating disorders is increased in elite athletes and for this group the cause of starting to diet is related to (a) perception of the paradigm of appearance in the specific sport, (b) perceived performance improvements, and (c) sociocultural pressures for thinness or an "ideal" body. Athletes most at risk for disordered eating are those involved in sports emphasizing a thin body size/shape, a high power-to-weight ratio, and/or sports utilizing weight categ…

medicine.medical_specialtybiologyBulimia nervosaOvertrainingbusiness.industryAthletesdigestive oral and skin physiologyPhysical Therapy Sports Therapy and RehabilitationAnorexia nervosamedicine.diseasebiology.organism_classificationCoachingEating disordersmedicineOrthopedics and Sports Medicinemedicine.symptomDisordered eatingPsychologybusinessPsychiatryhuman activitiesClinical psychologyDietingScandinavian Journal of Medicine & Science in Sports
researchProduct

Eating Disorders in Male and Female Athletes

2013

medicine.medical_specialtybiologybusiness.industryAthletesPrevalencePhysical activitymedicine.diseasebiology.organism_classificationEating disordersEpidemiologyMedicineHealth educationDisease preventionbusinessPsychiatry
researchProduct

Congenital Factor VII Deficiency

2007

medicine.medical_specialtybiologybusiness.industrymedicine.diseaseGastroenterologyThrombosisRecombinant factor VIIaInternal medicineImmunologymedicinebiology.proteinSubstitution therapybusinessInherited Coagulation DisordersFactor VII deficiency
researchProduct